Novel Coronavirus (COVID-19)

(posted 2/13/20)

As of today, 60,358 cases have been confirmed, primarily in China, with 1,370 reported deaths (CFR = 2.3%). There have been 14 laboratory-confirmed cases reported in the United States.  Wisconsin’s first case was reported on February 5, 2020.  This case was associated with direct travel to the People’s Republic of China.  Recent modelling (Wu et al. Lancet January 31, 2020 suggests a basic reproductive number of 2.68 (more transmittable then seasonal influenza) and an epidemic doubling time of 6.4 days.

Key Messages for Wisconsin Clinicians:

  • Continue to routinely ask patients about their travel history and collect specific information about locations (city, country) and dates of travel.
  • Work with your facility's infection prevention staff to review site-specific plans for the identification and isolation of patients and notify them immediately if any patients present with the clinical and epidemiologic criteria below.
  • Contact Wisconsin DPH at 608-267-9003 for consultation and approval of testing for 2019-nCoV for patients who meet the clinical and epidemiologic criteria below.
  • All clinical specimens from patients who are approved for testing must be accompanied by a completed patient under investigation (PUI) form and sent to the Wisconsin State Laboratory of Hygiene. At this time, all testing is performed at the CDC.

Criteria to Guide Evaluation of Patients Under Investigation (PUI) for 2019-nCoV:

Patients in the United States who meet the following criteria should be evaluated as a PUI in association with the outbreak of 2019-nCoV in Wuhan City, China.

1) Fever AND symptoms of lower respiratory illness (e.g., cough, shortness of breath)

–and in the last 14 days before symptom onset,

•   History of travel from Wuhan City, China


•   Close contact with a person who is under investigation for 2019-nCoV while that person was ill.


2) Fever OR symptoms of lower respiratory illness (e.g., cough, shortness of breath)

–and in the last 14 days before symptom onset,

•   Close contact with an ill laboratory-confirmed 2019-nCoV patient.

New Adult and Child-Adolescent Immunization Schedules

(posted 2/6/2020)

The new Adult and Child-Adolescent immunization schedules from the Advisory Committee on Immunization Practices of the United States Centers for Disease Control and Prevention (CDC) are now available for download at:

Laminated hard copies of schedules, with bulk order discounts, will be available for purchase from the Immunization Action Coalition in March. Sign up to get notified when they are available or click here.

Immunization Summit

Supporting Access Expansion and Vaccination Efficiency in Clinics and Communities

The Pharmacy Society of Wisconsin is hosting a summit for stakeholders interested in supporting immunization access expansion on Wednesday, February 26, 2020 at Glacier Canyon Conference Center in the Wisconsin Dells from 9 am – 4:30 pm. This event is for immunization providers and advocates, including immunization coalition representatives, clinic-based health care providers and teams, pharmacists, health plan leaders, and others with a passion for expanding access to immunizations. Click on READ MORE to register online and view the complete schedule. You can also download the PDF registration form and return it to the PSW office by email to or fax at 608.827.9292. To reserve a hotel room at Glacier Canyon Lodge, please call 1-800-867-9453 or go online and use the booking code #774008.

Sign up to the
WAFP Email List